Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Phase 3 Unknown
108 enrolled
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Phase 1 Unknown
10 enrolled
TUM-DC
Unknown
64 enrolled
AMPLE-3
Phase NA Unknown
160 enrolled
ILST
Phase NA Unknown
2,000 enrolled
SOLUCOM
Phase 2 Unknown
100 enrolled
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
Phase 1/2 Unknown
172 enrolled
AMT-151 in Patients With Selected Advanced Solid Tumours
Phase 1 Unknown
30 enrolled
IMMUNOs-SBRT
Phase 1 Unknown
92 enrolled
Patient-Derived Xenografts to Reduce Cancer Health Disparities
Unknown
500 enrolled
CAT_PB
Phase 1 Unknown
500 enrolled
Increasing Physical Activity Through Personalised Motivational Messaging to Improve Cognitive Function in Lung Cancer Survivors
Phase NA Unknown
120 enrolled
Adapting the Tumor Board Model for Mental Illness and Cancer
Phase NA Unknown
30 enrolled
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Phase 1/2 Unknown
314 enrolled
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
Phase 1/2 Unknown
186 enrolled
ELISA
Unknown
320 enrolled
Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer
Phase 2 Unknown
24 enrolled
PRECISION
Unknown
40 enrolled
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Unknown
3,000 enrolled
RESTORE
Phase NA Unknown
352 enrolled
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Unknown
133 enrolled
MICROBIOME
Phase 1 Unknown
120 enrolled
'Lung Health Check' Biomarker Study
Unknown
1,000 enrolled
PASSION
Unknown
1,800 enrolled
SALMON
Unknown
1,000 enrolled
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Unknown
279 enrolled
PREVALUNG
Phase NA Unknown
500 enrolled
Idylla EGFR Lung Trial
Unknown
150 enrolled
MIRACLE
Phase 2 Unknown
112 enrolled
Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer Patients
Unknown
200 enrolled
Routine Electronic Monitoring Of Quality Of Life -Poumon (REMOQOL-Poumon)
Unknown
72 enrolled
IMPE-F
Unknown
50 enrolled
MRI Lung
Phase NA Unknown
15 enrolled
PIONEER
Unknown
1,000 enrolled
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics
Unknown
130 enrolled
AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.
Unknown
30 enrolled
Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC
Phase 2 Unknown
20 enrolled
Oncogeriatric Intervention and Follow-up at Home
Phase NA Unknown
350 enrolled
ICI-DISCOVER
Unknown
200 enrolled
Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
Unknown
1,000 enrolled
The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients
Unknown
500 enrolled
OPTIMAL
Phase 2 Unknown
110 enrolled
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC
Phase 1/2 Unknown
20 enrolled
Monitoring and Telecoaching of Physical Activity in Patients With Stage III and IV Non-small Cell Lung Cancer
Phase NA Unknown
32 enrolled
SMART
Phase 2 Unknown
43 enrolled
A Study Evaluating MM-310 in Patients With Solid Tumors
Phase 1 Unknown
34 enrolled
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC
Phase 2 Unknown
144 enrolled
A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection
Phase 3 Unknown
417 enrolled
Dynamic PET CT as a Tool for Treatment Efficacy Monitoring in Lung Cancer
Unknown
200 enrolled
Circulating Tumor Cells Spillage After Pulmonary Biopsy
Phase NA Unknown
40 enrolled